Ion Beam Applications SA's latest marketcap:
As of 07/05/2025, Ion Beam Applications SA's market capitalization has reached $395.61 M. According to our data, Ion Beam Applications SA is the 15690th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 395.61 M |
| Revenue (ttm) | 586.56 M |
| Net Income (ttm) | 10.9 M |
| Shares Out | 29.27 M |
| EPS (ttm) | 0.37 |
| Forward PE | 18.82 |
| Ex-Dividend Date | 06/18/2025 |
| Earnings Date | 08/28/2025 |
Ion Beam Applications SA's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €395.61 M | -12.86% | 15690 |
| 12/31/2024 | €391.61 M | 16.33% | 14384 |
| 12/29/2023 | €336.64 M | -25.79% | 15011 |
| 12/30/2022 | €453.61 M | 2.56% | 12434 |
| 12/31/2021 | €442.27 M | 22.23% | 13325 |
| 12/31/2020 | €361.85 M | -5.81% | 12281 |
| 12/31/2019 | €384.15 M | 1.6% | 10785 |
| 12/31/2018 | €378.11 M | -45.95% | 9834 |
| 12/29/2017 | €699.54 M | -42.25% | 7932 |
| 12/30/2016 | €1.21 B | 25.81% | 5480 |
Company Profile
About Ion Beam Applications SA
Ion Beam Applications SA is a leading developer and manufacturer of medical devices and software solutions, specializing in advanced cancer treatments. Headquartered in Louvain-la-Neuve, Belgium, the company operates globally, serving healthcare providers in the United States and internationally.
Business Segments
- Proton Therapy and Other Accelerators: Designs, manufactures, and services medical and industrial particle accelerators, including proton therapy systems for cancer treatment. This segment also provides cyclotrons for radioisotope production and industrial accelerators for sterilization.
- Dosimetry: Delivers solutions and services to improve accuracy and efficiency in radiation therapy, medical imaging quality assurance, and calibration procedures.
Key Partnerships & Innovations
- Collaborates with SCK CEN (Belgian nuclear research center) to produce Actinium-225 (225Ac), a promising radioisotope for cancer therapy.
- Research agreement with the University of Pennsylvania to advance ConformalFLASH technology.
- Partners with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1.
Founded in 1986, Ion Beam Applications SA continues to drive innovation in radiation therapy and medical imaging, improving patient outcomes worldwide.
Frequently Asked Questions
-
What is Ion Beam Applications SA's (EBR-IBAB) current market cap?As of 07/05/2025, Ion Beam Applications SA (including the parent company, if applicable) has an estimated market capitalization of $395.61 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Ion Beam Applications SA (EBR-IBAB) rank globally by market cap?Ion Beam Applications SA global market capitalization ranking is approximately 15690 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.